Search for content, post, videos

STADA and Xbrane strengthen collaboration

Martin Åmark
The two companies have expanded their strategic biosimilar development partnership, which allows both companies to evaluate potential development and commercialization collaborations around Xbrane’s Xcimzane and Xdivane preclinical biosimilars and additional biosimilars that fit both companies’
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.